UNSPSC 51381903: Mofezolac

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51381903

Definition

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H17NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RVJ0BV3H3Y, chemically known as 3,4-bis(p-methoxyphenyl)-5-isoxazoleacetic acid but generally known as mofezolac, which bears US NIH Compound Identifier 4237. European Medicines Agency schedules Mofezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09035MIG.

Read the full definition

The term MOFEZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). MOFEZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mofezolac under HS 29349990 and SITC 51579. As of Q4 2014, MOFEZOLAC remains the US FDA Preferred Term for this commodity. Mofezolac bears US NLM identifiers UMLS ID C0043597 and NCI Concept Code C66176. SMILES: O1NC(C(C1CC(=O)O)C1CCC(OC)CC1)C1CCC(OC)CC1.

About UNSPSC 51381903

UNSPSC 51381903 Mofezolac is a Commodity code that in state and local procurement covers pharmaceutical products and drug-related supplies, though the single recent opportunity associated with the code reflects a broader scope of naloxone and drug deactivation systems rather than mofezolac specifically. State and local health and emergency-management agencies solicit under this family to stock naloxone, opioid-overdose reversal agents, and related harm-reduction supplies for community health programs and first-responder deployment. The issuing bodies are typically county health departments and community health authorities managing public-health initiatives tied to substance-use response and prevention.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, with bids submitted electronically through the county's e-Procurement Portal. Vendors must include all shipping and delivery costs, hold required insurance (workers' compensation, commercial general liability, professional liability), pass drug-free workplace certification and E-Verify compliance, and accept a three-month probationary termination clause. The contract carries a two-year initial term with a one-year renewal option and potential FEMA funding, which introduces compliance with the Clean Air Act and Federal Water Pollution Control Act. The opportunity shows limited recent state and local activity under this Commodity code; geographic and issuing-body diversification data are not supported by the source.

Quick answers

What is UNSPSC 51381903?

UNSPSC 51381903 is Mofezolac, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51381903?

UNSPSC 51381903 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51381903

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code